Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma

被引:0
|
作者
Ishihara, Hiroki [1 ]
Fukuda, Hironori [2 ]
Yoshida, Kazuhiko [2 ]
Hashimoto, Yasunobu [3 ]
Kondo, Tsunenori [1 ]
Takagi, Toshio [2 ]
机构
[1] Tokyo Womens Med Univ, Adachi Med Ctr, Dept Urol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[3] Saiseikai Kawaguchi Gen Hosp, Dept Urol, Saitama, Japan
关键词
brain metastases; immunotherapy; ipilimumab; nivolumab; RCC; STEREOTACTIC RADIOTHERAPY; THERAPY;
D O I
10.1111/iju.15086
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:240 / 242
页数:3
相关论文
共 50 条
  • [1] Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors
    Hanif, Ahmad
    Pandey, Manu
    Khan, Sumera
    Attwood, Kristopher
    George, Saby
    ONCOIMMUNOLOGY, 2019, 8 (08):
  • [2] Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
    Parikh, Mamta
    Bajwa, Poornima
    SEMINARS IN NEPHROLOGY, 2020, 40 (01) : 76 - 85
  • [3] A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin
    Kattan, Joseph
    El Rassy, Elie
    Assi, Tarek
    Bakouny, Ziad
    Pavlidis, Nicholas
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 130 : 60 - 69
  • [4] Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
    Nemoto, Yuki
    Ishihara, Hiroki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (01) : 47 - 54
  • [5] Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
    Resch, I.
    Bruchbacher, A.
    Franke, J.
    Fajkovic, H.
    Remzi, M.
    Shariat, S. F.
    Schmidinger, M.
    ESMO OPEN, 2021, 6 (04)
  • [6] Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Martin, Spencer D. D.
    Bhuiyan, Ishmam
    Soleimani, Maryam
    Wang, Gang
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [7] Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
    Yuki Nemoto
    Hiroki Ishihara
    Kazutaka Nakamura
    Hidekazu Tachibana
    Hironori Fukuda
    Kazuhiko Yoshida
    Hirohito Kobayashi
    Junpei Iizuka
    Hiroaki Shimmura
    Yasunobu Hashimoto
    Kazunari Tanabe
    Tsunenori Kondo
    Toshio Takagi
    International Urology and Nephrology, 2022, 54 : 47 - 54
  • [8] Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
    Chahoud, Jad
    Msaouel, Pavlos
    Ross, Jeremy A.
    McCormick, Barrett Z.
    Bathala, Tharakeswara K.
    Gao, Jianjun
    Horn, Robert
    Xiao, Lianchun
    Sircar, Kanishka
    Campbell, Matthew T.
    Shah, Amishi Y.
    Goswami, Sangeeta
    Zurita, Amado J.
    Jonasch, Eric
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Sharma, Padmanee
    Tannir, Nizar M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 134.e9 - 134.e16
  • [9] Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
    Gebrael, Georges
    Jo, Yeonjung
    Thomas, Vinay Mathew
    Li, Haoran
    Sayegh, Nicolas
    Tripathi, Nishita
    Srivastava, Ayana
    Nordblad, Blake
    Dal, Emre
    Narang, Arshit
    Brundage, James
    Campbell, Patrick
    Fortuna, Gliceida Galarza
    Chehade, Chadi Hage
    Maughan, Benjamin L.
    Agarwal, Neeraj
    Swami, Umang
    CANCER, 2024, 130 (15) : 2621 - 2628
  • [10] Editorial: Immune checkpoint inhibitors in renal cell carcinoma
    Tykodi, Scott S. S.
    Pichler, Renate
    FRONTIERS IN ONCOLOGY, 2023, 13